These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
627 related items for PubMed ID: 9703380
1. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men. Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD. Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380 [Abstract] [Full Text] [Related]
2. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms. Shah N, Evans WS, Bowers CY, Veldhuis JD. J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723 [Abstract] [Full Text] [Related]
7. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Veldhuis JD. J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385 [Abstract] [Full Text] [Related]
8. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Awouters M, Verbruggen W, Schetz M, Verwaest C, Lauwers P, Bouillon R, Bowers CY. J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260 [Abstract] [Full Text] [Related]
9. Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release. Friend K, Iranmanesh A, Login IS, Veldhuis JD. Eur J Endocrinol; 1997 Oct; 137(4):377-86. PubMed ID: 9368506 [Abstract] [Full Text] [Related]
11. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men. Gentili A, Mulligan T, Godschalk M, Clore J, Patrie J, Iranmanesh A, Veldhuis JD. J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328 [Abstract] [Full Text] [Related]
17. The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men. Haijma SV, van Dam PS, de Vries WR, Maitimu-Smeele I, Dieguez C, Casanueva FF, Koppeschaar HP. Eur J Endocrinol; 2005 Apr; 152(4):575-80. PubMed ID: 15817913 [Abstract] [Full Text] [Related]
18. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism. Veldhuis JD, Keenan DM, Bailey JN, Miles JM, Bowers CY. Eur J Endocrinol; 2009 Aug; 161(2):293-300. PubMed ID: 19458139 [Abstract] [Full Text] [Related]
20. Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females--a general clinical research center-based study. Veldhuis JD, Roemmich JN, Rogol AD. J Clin Endocrinol Metab; 2000 Jul; 85(7):2385-94. PubMed ID: 10902783 [Abstract] [Full Text] [Related] Page: [Next] [New Search]